The aim is to observe whether there is a territorial similarity of changes in mortality due to selected causes in Poland in the years 2002–2017. Convergence models were used to verify the hypothesis that, since Poland's accession to the EU, the country has seen a spatial convergence of mortality due to major causes of death.
The country's provinces have been homogenising in terms of death intensity levels evening out for the majority of examined groups of causes. This is indicated by the confirmed absolute beta-convergence for most variables, including the two major causes of death: I00–I99 and C00–D48. However, a confirmation of beta-convergence does not always apply to both a broader and a narrower group of causes. In turn, sigma-divergence of mortality due to most of the examined causes in Poland's provinces indicates increasing variation in the years 2002–2017, which means that the provinces were not becoming similar. Such findings indicate that the formulated hypothesis has not been confirmed.
Analysis of changes in population processes in various communities shows that, frequently, their trajectory becomes increasingly similar over time (Wilson, 2011). The changes generalise the demographic transition theories that characterise both the first and second demographic transitions. The first demographic transition describes dropping death and fertility rates, initially accompanied by a growing natural increase rate, then followed by a drop. Over time, the direction and pace of changes in birth and death rates began to converge in a growing number of countries (Chesnais, 1986). In most countries in which the first demographic transition had ended, the expected stabilisation of mortality and fertility was disturbed in the 1960s. The new transformations, referred to as the “second demographic transition”, consisted in, for instance, falling birth rates and a further decrease in mortality, leading to longer life spans. This character and direction of population process transformations suggested that countries with a high death intensity would follow those in which mortality is lower and, consequently, the length of life in various communities would be evening out. Thus, convergence would be taking place.
The concept of convergence was at the core of demographic transition theory. Palloni (1981) formulated a thesis that changes in mortality are irreversible and have the same directions in various populations, which results in any differences between them being blurred. The point of reference in studying convergence of mortality was epidemiological transition theory (Omran, 1971), which explains long-term changes in morbidity and mortality patterns. Despite criticism, Vallin and Meslé integrated the theory (2004) as the first stage of the global health transformation process. Although in the first half of the 20th century no formal attempts were made to verify the concept of convergence (Wilson, 2001), in the 21st century, studies on countries in Europe, North America and Latin America have been conducted using, for instance, convergence models. The following variables have been used in the studies: life expectancy at birth, infant mortality, and standardised death rates by sex and age. The results of research into convergence of mortality have differed. Spinakis et al. (2011) found divergence of mortality of elderly persons in 27 European Union countries in the years 1997–2008. Alvarez, Aburto and Canudas-Romo (2020) proved the existence of regional differences in infant life expectancy in 20 Latin American countries in the years 2000–2014.
Vallin and Meslé (2004) showed that the appearance of new health threats (e.g. AIDS) and the introduction of new, expensive medical technologies caused changes in death intensity in developing countries not to follow the path of highly developed countries. The similarity of previously observed changes in length of life was stopped. McMichael et al. (2004) argued, showing diversified changes in the length of life in countries on various continents, that future health benefits are not guaranteed by the determinism of the convergence process, and that increased heterogeneity of changes in the mortality process in different populations should be expected. Mackenbach et al. (2017) showed that the disproportions in mortality in 17 European countries in the years 1970–2010 resulted from a diversified impact of behavioural risk factors (tobacco smoking, excessive alcohol consumption) and social factors (poverty, national economic, political and cultural conditions).
The observable discrepancies in mortality changes in different countries drew attention to studies into regional convergence, especially NUTS2 and NUTS3. Gächter and Theurl (2011) analysed the similarity of changes in the state of health in the federated states of Austria, which is a relatively homogenous country. The state of health was expressed by means of standardised death rates. After analysing changes in total death intensity and death intensity by sex, the authors confirmed the occurrence of beta-convergence of mortality rates between examined populations. One of the possible reasons for the changes they identified was the federal government's efforts aimed at the country's harmonious development.
For much of the 20th century, Poland's changes in mortality were highly unsatisfactory, and there were periods in which death intensity was in fact growing. The process was also significantly territorially differentiated (Pułaska-Turyna, 1990; Wojtyniak & Goryński, 2018). Since Poland's accession to the EU, the central government and local self-governments have had funds at their disposal for evening out differences in the regions’ socio-economic situation. The goal of the study presented here was to find out whether the steps taken in recent years, which have been partly financed by EU funds, have contributed, as intended, to eliminating the differences. In connection with the above, the following hypothesis was formulated: in Poland, since its accession to the EU, there has occurred a spatial convergence in mortality due to major causes of death.
Similarities in changes in mortality in Poland were analysed based on standardised death rates in individual provinces (voivodeships). Death intensity was measured using rates characterising deaths due to selected causes. In Poland, as in many countries, the most common causes of death include (relevant International Statistical Classifications of Diseases and Related Health Problems (ICD-10) are given in parentheses): neoplasms (C00–D48), diseases of the circulatory system (I00–I99), diseases of the respiratory system (J00–J99), diseases of the digestive system (K00–K93) and external causes of death (V01–Y89). In 2018, those caused 82.7% of all deaths. Within those broad groups of causes, the impact of individual diseases differs. To evaluate mortality convergence or divergence, the diseases causing most deaths in each group were selected. The circulatory system diseases included: ischaemic heart diseases (I20–I25), cerebrovascular diseases (I60–I69); and neoplasms included: malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal (C18–C21), malignant neoplasm of stomach (C16), malignant neoplasm of trachea, bronchus and lung (C33, C34). The most common causes of death were: among the respiratory system diseases – chronic lower respiratory diseases (J40–J47) and pneumonia (J12–J18); and among the digestive system diseases – chronic liver disease (K70, K73, K74). As regards external causes of death and poisonings, mortality due to the following causes was analysed: transport accidents (V01–V99, Y85) and intentional self-harm (X60–X84, Y870).
For the listed 15 causes of death (broad and narrow groups of causes), data about standardised death rates were collected for Poland's 16 provinces in the years 2002–2017. In the case of mortality caused by C33–C34, the data covered the years 2007–2017. The data came from the Eurostat database (2020a; 2020b), in which Europe's population structure was used for standardisation. The rate values for the years 2002–2010 were smoothed using a moving average, whereas the values for the period 2011–2017 were not. Despite the different ways of presenting the death rates, it was decided to use both sets of data, recognising that the smoothing of values only eliminates the impact of accidental fluctuations on regularities observed over time. The missing death rates for the examined causes for six provinces for the years 2011 and 2012 were supplemented by linear interpolation.
Figures 1 and 2 show standardised death rates due to five groups of death causes in the years 2002 and 2017, respectively. The provinces were divided into quartile groups in the two years. An examination of the maps indicates that there were significant changes in the intensity of deaths due to the selected groups of causes between 2017 and 2002 in a few cases. Only in the case of diseases of the circulatory system did Podkarpackie province move from the fourth quartile group in 2002 to the first in 2017, which reflects a significant improvement in the situation in the area. A similar improvement is visible in the case of Lubuskie and Świętokrzyskie provinces as regards mortality due to diseases of the respiratory system. In the other cases, 2017 as compared with 2002 saw smaller changes in death intensity, or there was no change in the relative position of a given province (belongingness to a specific quartile group) in the studied community.
Fig. 1
Standardised death rates by selected causes in Poland's provinces in 2002
Source: own work based on acquired data (Eurostat 2020a)

Fig. 2
Standardised death rates by selected causes in Poland's provinces in 2017
Source: own work based on acquired data (Eurostat 2020b)

A comparison of the values of the measures of death intensity in the extreme years of the period in question indicates that their inter-province variation decreased most for the causes responsible for the biggest number of deaths. The range, i.e. the difference between the units with the highest and smallest mortality, decreased by nearly a half for respiratory diseases and by a third for neoplasms (Table 1). The falling variation was accompanied by a drop in death intensity due to the diseases. The opposite is true for diseases of the respiratory system. The variation in standardised death rates fell, while values in 2017 as compared with 2002 rose. For diseases of the digestive system and external causes, the variation in death intensity in the provinces increased in 2017 in comparison with 2002.
Range of standardised death rates by selected groups of causes in Poland's provinces, 2002 and 2017
109.8 | 74.8 | ||
Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal C18–C21 | 14.5 | 12.8 | 88.3% |
Malignant neoplasm of stomach C16 | 9.2 | 7.3 | 79.3% |
Malignant neoplasm of trachea, bronchus and lung C33, C34 | 29.1 | 34.9 | 119.9% |
300.0 | 163.7 | ||
Ischaemic heart diseases I20–I25 | 171.1 | 240.1 | 140.3% |
Cerebrovascular diseases I60–I69 | 91.6 | 33.0 | 36.0% |
57.8 | 48.0 | ||
Chronic lower respiratory diseases J40–J47 | 24.8 | 20.4 | 82.3% |
Pneumonia J12–J18 | 40.2 | 40.2 | 100.0% |
25.0 | 27.6 | ||
Chronic liver disease K70, K73, K74 | 13.3 | 13.0 | 97.7% |
22.6 | 22.9 | ||
Transport accidents V01–V99, Y85 | 10.2 | 5.4 | 52.9% |
Intentional self-harm X60–X84, Y870 | 8.2 | 11.4 | 139.0% |
Changes in the ranges of rates of death due to a given group of causes do not mean that the variation in mortality due to individual causes was changing in the same way. Indices of range dynamics for the major individual causes of death show that, in the selected groups of causes, the variation measured by the range changed in various directions, e.g. in the I00–I99 group of causes the variation of mortality due to cerebrovascular diseases I60–I69 dropped significantly, while it grew for ischaemic heart diseases I20–I25.
To examine similarities of spatial mortality changes, the absolute beta- and sigma-convergence models were used (Barro, Sala-i-Martin, 1992; Boyle, McCarthy, 1997; Sala-i-Martin, 1996). This analysis method has been and is primarily used to investigate the similarity of changes in economic phenomena, but it is also applied in investigating demographic processes (Krupowicz & Kuropka, 2019). Where beta-convergence was found to occur, the character of the observed changes was identified. In was then indicated which provinces had been catching up or falling behind, and which had been distancing themselves or marginalising, approaching the value of the analysed variable.
Absolute beta-convergence was verified by means of a cross-sectional regression model in the form:
The model parameters (1) were estimated by least squares method (LSM). The significance of the parameter
Based on the parameter
A positive value of the rate
Based on the regression model of variation measure over time, sigma-convergence was verified as follows (Friedman, 1992):
The parameters of the model (3) were also estimated using LSM. The significance of the parameter
Sigma-convergence (or divergence) was subject to confirmation by the variance change test. Where sigma-convergence was suspected, the significance of the variance drop in the initial and final periods was tested. On the other hand, a supposed occurrence of sigma-divergence was tested by checking the significance of variance growth in the compared periods.
A test of the significance of the parameter
Using data regarding standardised death rates by selected groups of causes in Poland's provinces, models were constructed (1). The results of estimation of the model parameters and their verification with Student's
Parameters of models of absolute beta-convergence of mortality by selected causes in Poland's provinces, 2002–2017
−0.2111 ** | 1.1489 | 0.2013 | 1.6% | |
Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal C18–C21 | −0.3720 ** | 1.3633 | 0.3263 | 3.1% |
Malignant neoplasm of stomach C16 | −0.2196 | 0.1815 | 0.0314 | 1.7% |
Malignant neoplasm of trachea, bronchus and lung C33, C34 | −0.0834 | 0.3263 | 0.0146 | 0.9% |
−0.7308 ** | 4.5076 | 0.4715 | 8.7% | |
Ischaemic heart diseases I20–I25 | −0.8508 ** | 4.0945 | 0.2580 | 12.7% |
Cerebrovascular diseases I60–I69 | −0.9096 ** | 4.0962 | 0.5705 | 16.0% |
−0.9121 ** | 4.0201 | 0.5310 | 16.2% | |
Chronic lower respiratory diseases J40–J47 | −0.1208 | 0.0432 | 0.0071 | 0.9% |
Pneumonia J12–J18 | −0.6958 ** | 2.8055 | 0.5659 | 7.9% |
0.0836 | −0.5278 | 0.0055 | −0.5% | |
Chronic liver disease K70, K73, K74 | −0.5006 ** | 1.4946 | 0.3508 | 4.6% |
−0.2548 | 0.7199 | 0.0716 | 2.0% | |
Transport accidents V01–V99, Y85 | −0.5261 ** | 0.8408 | 0.1936 | 5.0% |
Intentional self-harm X60–X84, Y870 | −0.8194 * | 1.9579 | 0.1457 | 11.4% |
– statistically significant at α = 0.05;
– statistically significant at α = 0.1
The tempo of convergence of mortality by cause, as defined by the coefficient of convergence
To identify the nature of the convergence between provinces’ changes in mortality by cause, the examined units were divided into groups. The groupings were determined according to the value of the variable (cause-specific death rates) in a given province in the year 2002 and the dynamics of the changes in the examined variable in the period 2002–2017 relative to mean values. The mean values were calculated as the coefficients of the centre of gravity of the model (1). Convergence may consist in catching up or falling behind, while divergence can consist in marginalising or distancing. The results of the grouping for the ten variables with a confirmed beta-convergence are presented in Table 3.
Character of convergence of mortality by selected causes in Poland's provinces, 2002–2017
Specification | Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal C18–C21 | Ischaemic heart diseases I20–I25 | Cerebrovascular diseases I60–I69 | Pneumonia J12–J18 | Chronic liver disease K70, K73, K74 | Transport accidents V01–V99, Y85 | Intentional self-harm X60–X84, Y870 | |||
---|---|---|---|---|---|---|---|---|---|---|
Dolnośląskie | D | D | S | M | C | C | C | S | C | S |
Kujawsko-pomorskie | D | S | S | S | C | S | S | M | S | M |
Lubelskie | C | C | D | C | S | M | C | S | C | C |
Lubuskie | D | D | C | C | D | S | M | C | C | D |
Łódzkie | D | S | S | M | S | S | S | S | S | D |
Małopolskie | M | C | S | C | M | C | C | C | M | S |
Mazowieckie | M | M | M | S | S | D | S | S | S | C |
Opolskie | M | D | D | S | S | C | C | M | M | M |
Podkarpackie | C | C | S | S | C | C | C | C | M | S |
Podlaskie | M | M | C | C | C | D | S | C | D | S |
Pomorskie | S | S | C | D | C | D | D | C | S | C |
Śląskie | D | D | S | S | S | M | S | S | M | M |
Świętokrzyskie | C | M | D | S | S | S | S | C | D | C |
Warmińsko-mazurskie | S | C | C | C | S | S | S | D | S | D |
Wielkopolskie | D | S | S | S | D | C | C | S | D | S |
Zachodniopomorskie | S | D | D | S | C | C | C | D | S | S |
The conducted classification indicates that, in the years 2002–2017, in most of Poland's provinces, mortality by the selected causes was subject to slowing-down or catching-up convergence. The convergence of mortality due to diseases of the circulatory system was of the slowing-down nature in seven provinces (Dolnośląskie, Kujawskopomorskie, Łódzkie, Małopolskie, Podkarpackie, Śląskie and Wielkopolskie). In those provinces with above-average mortality, the tempo of change in intensity of deaths was below average. In four provinces (Lubuskie, Podlaskie, Pomorskie and Warmińsko-mazurskie), the mortality due to I00–I99 had the catching-up nature. In those administrative units with below-average death intensity, the tempo of change in mortality was above average.
It was only in the case of mortality due to neoplasms that distancing or marginalising divergence occurred. This individual divergence does not match the convergence confirmed with model (1). The parameter
In the case of mortality due to C18–C21, the effects making up the convergence or divergence processes were distributed nearly evenly across all provinces. Slowing down and catching up occurred in four provinces each, while five provinces experienced a distancing and three a marginalising.
To check if there was sigma-convergence of mortality by the selected causes, the coefficient of variation of logarithms of death rates in the provinces in the years 2002–2017 was calculated. The estimated parameters of the models (3) are presented in Table 4.
Parameters of models of sigma-convergence of mortality by the selected causes in Poland's provinces, 2002–2017
0.0000 | 0.0143 | 0.0037 | |
Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal C18–C21 | −0.0005 ** | 0.0340 | 0.3133 |
Malignant neoplasm of stomach C16 | 0.0009 ** | 0.0352 | 0.3712 |
Malignant neoplasm of trachea, bronchus and lung C33, C34 | 0.0008 ** | 0.0283 | 0.7541 |
−0.0001 | 0.0149 | 0.1130 | |
Ischaemic heart diseases I20–I25 | 0.0025 ** | 0.0398 | 0.6584 |
Cerebrovascular diseases I60–I69 | 0.0005 * | 0.0293 | 0.1516 |
0.0008 ** | 0.0467 | 0.2514 | |
Chronic lower respiratory diseases J40–J47 | 0.0038 ** | 0.0280 | 0.6617 |
Pneumonia J12–J18 | −0.0015 ** | 0.1111 | 0.3022 |
0.0025 ** | 0.0196 | 0.5547 | |
Chronic liver disease K70, K73, K74 | −0.0006 ** | 0.0815 | 0.2173 |
0.0010 ** | 0.0203 | 0.4516 | |
Transport accidents V01–V99, Y85 | 0.0031 ** | 0.0495 | 0.8093 |
Intentional self-harm X60–X84, Y870 | 0.0046 ** | 0.0294 | 0.7487 |
– statistically significant at α = 0.05;
– statistically significant at α = 0.1
In most situations, the coefficients of variation tended to grow, which was attested to by the positive values of the parameters
The statistical significance test performed on the coefficient of variation of cause-specific death rates was supplemented with a test of significance of the variance growth (or fall) in the beginning (2002) and end (2017) of the study period. The verification results have been collected in Table 5.
Sigma-convergence – variance test, statistics – mortality by selected causes in Poland's provinces, 2002–2017
0.0086 | 0.0069 | 1.2513 | – | 0.3348 | |
Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal C18–C21 | 0.0156 | 0.0106 | 1.4704 | – | 0.2321 |
Malignant neoplasm of stomach C16 | 0.0117 | 0.0246 | – | 2.0964 | 0.0816 |
Malignant neoplasm of trachea, bronchus and lung C33, C34 | 0.0158 | 0.0207 | – | 1.3082 | 0.3047 |
0.0124 | 0.0083 | 1.4904 | – | 0.2243 | |
Ischaemic heart diseases I20–I25 | 0.0683 | 0.1438 | – | 2.1036 | 0.0807 |
Cerebrovascular diseases I60–I69 | 0.0198 | 0.0125 | 1.5847 | – | 0.1913 |
0.0501 | 0.0372 | 1.3467 | – | 0.2857 | |
Chronic lower respiratory diseases J40–J47 | 0.0284 | 0.0797 | – | 2.8031 | 0.0273 |
Pneumonia J12–J18 | 0.1317 | 0.0611 | 2.1556 | – | 0.0741 |
0.0140 | 0.0340 | – | 2.4345 | 0.0476 | |
Chronic liver disease K70, K73, K74 | 0.0458 | 0.0326 | 1.4022 | – | 0.2603 |
0.0081 | 0.0113 | – | 1.3974 | 0.2625 | |
Transport accidents V01–V99, Y85 | 0.0270 | 0.0372 | – | 1.3771 | 0.2716 |
Intentional self-harm X60–X84, Y870 | 0.0191 | 0.0758 | – | 3.9709 | 0.0056 |
Although for most examined causes of death the dispersion of mortality between provinces increased (Table 4), only in eight cases was the variance higher in the final period than in the initial one (Table 5). The variance increase was statistically significant in five situations, i.e. mortality due to: diseases of the digestive system, chronic lower respiratory diseases, intentional self-harm, ischaemic heart diseases and malignant neoplasm of the stomach. For seven causes of death, the variance in the death rates decreased, but only for mortality due to pneumonia was the drop statistically significant.
A review of the literature has shown that the adopted set of variables and geographical coverage of our study make our findings non-comparable against the results of any other study. However, our conclusions regarding convergence of mortality coincide with results confirming beta-convergence and not confirming sigma-convergence of infant life expectancy in the Netherlands in a longer time horizon, which meant that the regional differences in mortality did not change (Janssen et al., 2016). Also, the rates of deaths, including those due to neoplasms, for the EU regions for the years 1995–2011 did not indicate an average decrease in dispersion over time, but only the catching-up effect in the regions (Maynou & Saez, 2016). Cavallieri and Ferrante (2020) confirmed convergence of infant mortality and infant life expectancy in 20 regions of Italy in the years 1996–2016. Regional convergence of the state of health expressed as infant life expectancy in the EU countries has been confirmed in some studies (Jaworska, 2011; Maynou et al., 2015; Stańczyk, 2016).
The hypothesis that since Poland's accession to the EU the country has experienced spatial convergence of mortality due to major causes of death has not been confirmed. The research findings show that the provinces have been becoming alike in terms of death intensity levels evening out for most examined groups of causes. This is indicated by the confirmed absolute beta-convergence for most variables, including two major groups of causes of death: I00–I99 and C00–D48 (Table 6). However, a confirmation of beta-convergence does not always apply to both a broader and a narrower group of causes. It was observed that the tempo of convergence varied. One of the lowest ones regarded mortality due to neoplasms, and the highest one was for mortality due to diseases of the respiratory system.
Confirmation of type of convergence of mortality due to selected causes in Poland's provinces, 2002–2017
Yes | – | – | Opposite | |
Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal C18–C21 | Yes | Yes | – | Decrease |
Malignant neoplasm of stomach C16 | – | (Yes) | (Yes*) | Increase |
Malignant neoplasm of trachea, bronchus and lung C33, C34 | – | (Yes) | – | Increase |
Yes | – | – | Decrease | |
Ischaemic heart diseases I20–I25 | Yes | (Yes) | (Yes*) | Increase |
Cerebrovascular diseases I60–I69 | Yes | (Yes*) | – | Opposite |
Yes | (Yes) | – | Opposite | |
Chronic lower respiratory diseases J40–J47 | – | (Yes) | (Yes) | Increase |
Pneumonia J12–J18 | Yes | Yes | Yes* | Decrease |
– | (Yes) | (Yes) | Increase | |
Chronic liver disease K70, K73, K74 | Yes | Yes | – | Decrease |
– | (Yes) | – | Increase | |
Transport accidents V01–V99, Y85 | Yes | (Yes) | – | Increase |
Intentional self-harm X60–X84, Y870 | Yes* | (Yes) | (Yes) | Increase |
– at α = 0.1
In the years 2002–2017, in Poland's provinces, the intensity of deaths due to the examined causes was generally growing increasingly diversified, and so the provinces were not becoming similar to one another. Only for three of the causes of mortality (pneumonia, chronic liver disease and malignant neoplasm of the colon) did variation decrease, indicating that the provinces were becoming alike. A test of the directional coefficient of regression and a test of variance indicated the same direction of changes in the variation of mortality by cause – for eight causes it was an increase, and for four it was a decrease (Table 6). For three causes of death (neoplasms, diseases of the respiratory system, cerebrovascular diseases) the direction was opposite. Both tests for variation over time confirmed sigma-divergence only for five mortality causes (malignant neoplasm of stomach, ischaemic heart diseases, chronic lower respiratory diseases, diseases of the digestive system and intentional self-harm), and sigma-convergence for intensity of deaths due to pneumonia. Furthermore, in two broad groups of death causes (diseases of the circulatory system and neoplasms), neither convergence (i.e. becoming alike) nor divergence of mortality in the provinces was confirmed (Table 6). This multi-directional nature of the findings does not allow conclusions to be drawn as to convergence or divergence between provinces in terms of mortality by major causes that would not raise any doubt. This warrants the claim that the financial support provided so far under the cohesion programmes aimed at eliminating socioeconomic differences between provinces has proven ineffective. One reason might be that the principal determinant of state of health is lifestyle, and its changes are impossible to see over a short period of time.
Fig. 1

Fig. 2

Range of standardised death rates by selected groups of causes in Poland's provinces, 2002 and 2017
109.8 | 74.8 | ||
Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal C18–C21 | 14.5 | 12.8 | 88.3% |
Malignant neoplasm of stomach C16 | 9.2 | 7.3 | 79.3% |
Malignant neoplasm of trachea, bronchus and lung C33, C34 | 29.1 | 34.9 | 119.9% |
300.0 | 163.7 | ||
Ischaemic heart diseases I20–I25 | 171.1 | 240.1 | 140.3% |
Cerebrovascular diseases I60–I69 | 91.6 | 33.0 | 36.0% |
57.8 | 48.0 | ||
Chronic lower respiratory diseases J40–J47 | 24.8 | 20.4 | 82.3% |
Pneumonia J12–J18 | 40.2 | 40.2 | 100.0% |
25.0 | 27.6 | ||
Chronic liver disease K70, K73, K74 | 13.3 | 13.0 | 97.7% |
22.6 | 22.9 | ||
Transport accidents V01–V99, Y85 | 10.2 | 5.4 | 52.9% |
Intentional self-harm X60–X84, Y870 | 8.2 | 11.4 | 139.0% |
Parameters of models of absolute beta-convergence of mortality by selected causes in Poland's provinces, 2002–2017
−0.2111 |
1.1489 | 0.2013 | 1.6% | |
Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal C18–C21 | −0.3720 |
1.3633 | 0.3263 | 3.1% |
Malignant neoplasm of stomach C16 | −0.2196 | 0.1815 | 0.0314 | 1.7% |
Malignant neoplasm of trachea, bronchus and lung C33, C34 | −0.0834 | 0.3263 | 0.0146 | 0.9% |
−0.7308 |
4.5076 | 0.4715 | 8.7% | |
Ischaemic heart diseases I20–I25 | −0.8508 |
4.0945 | 0.2580 | 12.7% |
Cerebrovascular diseases I60–I69 | −0.9096 |
4.0962 | 0.5705 | 16.0% |
−0.9121 |
4.0201 | 0.5310 | 16.2% | |
Chronic lower respiratory diseases J40–J47 | −0.1208 | 0.0432 | 0.0071 | 0.9% |
Pneumonia J12–J18 | −0.6958 |
2.8055 | 0.5659 | 7.9% |
0.0836 | −0.5278 | 0.0055 | −0.5% | |
Chronic liver disease K70, K73, K74 | −0.5006 |
1.4946 | 0.3508 | 4.6% |
−0.2548 | 0.7199 | 0.0716 | 2.0% | |
Transport accidents V01–V99, Y85 | −0.5261 |
0.8408 | 0.1936 | 5.0% |
Intentional self-harm X60–X84, Y870 | −0.8194 |
1.9579 | 0.1457 | 11.4% |
Sigma-convergence – variance test, statistics – mortality by selected causes in Poland's provinces, 2002–2017
0.0086 | 0.0069 | 1.2513 | – | 0.3348 | |
Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal C18–C21 | 0.0156 | 0.0106 | 1.4704 | – | 0.2321 |
Malignant neoplasm of stomach C16 | 0.0117 | 0.0246 | – | 2.0964 | 0.0816 |
Malignant neoplasm of trachea, bronchus and lung C33, C34 | 0.0158 | 0.0207 | – | 1.3082 | 0.3047 |
0.0124 | 0.0083 | 1.4904 | – | 0.2243 | |
Ischaemic heart diseases I20–I25 | 0.0683 | 0.1438 | – | 2.1036 | 0.0807 |
Cerebrovascular diseases I60–I69 | 0.0198 | 0.0125 | 1.5847 | – | 0.1913 |
0.0501 | 0.0372 | 1.3467 | – | 0.2857 | |
Chronic lower respiratory diseases J40–J47 | 0.0284 | 0.0797 | – | 2.8031 | 0.0273 |
Pneumonia J12–J18 | 0.1317 | 0.0611 | 2.1556 | – | 0.0741 |
0.0140 | 0.0340 | – | 2.4345 | 0.0476 | |
Chronic liver disease K70, K73, K74 | 0.0458 | 0.0326 | 1.4022 | – | 0.2603 |
0.0081 | 0.0113 | – | 1.3974 | 0.2625 | |
Transport accidents V01–V99, Y85 | 0.0270 | 0.0372 | – | 1.3771 | 0.2716 |
Intentional self-harm X60–X84, Y870 | 0.0191 | 0.0758 | – | 3.9709 | 0.0056 |
Confirmation of type of convergence of mortality due to selected causes in Poland's provinces, 2002–2017
Yes | – | – | Opposite | |
Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal C18–C21 | Yes | Yes | – | Decrease |
Malignant neoplasm of stomach C16 | – | (Yes) | (Yes |
Increase |
Malignant neoplasm of trachea, bronchus and lung C33, C34 | – | (Yes) | – | Increase |
Yes | – | – | Decrease | |
Ischaemic heart diseases I20–I25 | Yes | (Yes) | (Yes |
Increase |
Cerebrovascular diseases I60–I69 | Yes | (Yes |
– | Opposite |
Yes | (Yes) | – | Opposite | |
Chronic lower respiratory diseases J40–J47 | – | (Yes) | (Yes) | Increase |
Pneumonia J12–J18 | Yes | Yes | Yes |
Decrease |
– | (Yes) | (Yes) | Increase | |
Chronic liver disease K70, K73, K74 | Yes | Yes | – | Decrease |
– | (Yes) | – | Increase | |
Transport accidents V01–V99, Y85 | Yes | (Yes) | – | Increase |
Intentional self-harm X60–X84, Y870 | Yes |
(Yes) | (Yes) | Increase |
Parameters of models of sigma-convergence of mortality by the selected causes in Poland's provinces, 2002–2017
0.0000 | 0.0143 | 0.0037 | |
Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal C18–C21 | −0.0005 |
0.0340 | 0.3133 |
Malignant neoplasm of stomach C16 | 0.0009 |
0.0352 | 0.3712 |
Malignant neoplasm of trachea, bronchus and lung C33, C34 | 0.0008 |
0.0283 | 0.7541 |
−0.0001 | 0.0149 | 0.1130 | |
Ischaemic heart diseases I20–I25 | 0.0025 |
0.0398 | 0.6584 |
Cerebrovascular diseases I60–I69 | 0.0005 |
0.0293 | 0.1516 |
0.0008 |
0.0467 | 0.2514 | |
Chronic lower respiratory diseases J40–J47 | 0.0038 |
0.0280 | 0.6617 |
Pneumonia J12–J18 | −0.0015 |
0.1111 | 0.3022 |
0.0025 |
0.0196 | 0.5547 | |
Chronic liver disease K70, K73, K74 | −0.0006 |
0.0815 | 0.2173 |
0.0010 |
0.0203 | 0.4516 | |
Transport accidents V01–V99, Y85 | 0.0031 |
0.0495 | 0.8093 |
Intentional self-harm X60–X84, Y870 | 0.0046 |
0.0294 | 0.7487 |
Character of convergence of mortality by selected causes in Poland's provinces, 2002–2017
Specification | Malignant neoplasm of colon, rectosigmoid junction, rectum, anus and anal canal C18–C21 | Ischaemic heart diseases I20–I25 | Cerebrovascular diseases I60–I69 | Pneumonia J12–J18 | Chronic liver disease K70, K73, K74 | Transport accidents V01–V99, Y85 | Intentional self-harm X60–X84, Y870 | |||
---|---|---|---|---|---|---|---|---|---|---|
Dolnośląskie | D | D | S | M | C | C | C | S | C | S |
Kujawsko-pomorskie | D | S | S | S | C | S | S | M | S | M |
Lubelskie | C | C | D | C | S | M | C | S | C | C |
Lubuskie | D | D | C | C | D | S | M | C | C | D |
Łódzkie | D | S | S | M | S | S | S | S | S | D |
Małopolskie | M | C | S | C | M | C | C | C | M | S |
Mazowieckie | M | M | M | S | S | D | S | S | S | C |
Opolskie | M | D | D | S | S | C | C | M | M | M |
Podkarpackie | C | C | S | S | C | C | C | C | M | S |
Podlaskie | M | M | C | C | C | D | S | C | D | S |
Pomorskie | S | S | C | D | C | D | D | C | S | C |
Śląskie | D | D | S | S | S | M | S | S | M | M |
Świętokrzyskie | C | M | D | S | S | S | S | C | D | C |
Warmińsko-mazurskie | S | C | C | C | S | S | S | D | S | D |
Wielkopolskie | D | S | S | S | D | C | C | S | D | S |
Zachodniopomorskie | S | D | D | S | C | C | C | D | S | S |